求助PDF
{"title":"非小细胞肺癌(NSCLC)抗pd1免疫治疗患者选择的改进分析肿瘤突变负担和反转录转座子活性作为可能的有效性新生物标志物","authors":"C. Manuel","doi":"10.23937/2469-5807/1510068","DOIUrl":null,"url":null,"abstract":"Citation: Cobo-Dols M (2018) Improvement in the Selection of Patients for Anti-PD1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) Analyzing Tumor Mutational Burden and Retrotransposon Activity as Possible New Biomarker of Effectiveness. Int J Pathol Clin Res 4:068. doi.org/10.23937/24695807/1510068 Accepted: May 28, 2018: Published: May 30, 2018 Copyright: © 2018 Cobo-Dols M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":444147,"journal":{"name":"International Journal of Pathology and Clinical Research","volume":"65 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improvement in the Selection of Patients for Anti-PD1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) Analyzing Tumor Mutational Burden and Retrotransposon Activity as Possible New Biomarker of Effectiveness\",\"authors\":\"C. Manuel\",\"doi\":\"10.23937/2469-5807/1510068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Citation: Cobo-Dols M (2018) Improvement in the Selection of Patients for Anti-PD1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) Analyzing Tumor Mutational Burden and Retrotransposon Activity as Possible New Biomarker of Effectiveness. Int J Pathol Clin Res 4:068. doi.org/10.23937/24695807/1510068 Accepted: May 28, 2018: Published: May 30, 2018 Copyright: © 2018 Cobo-Dols M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.\",\"PeriodicalId\":444147,\"journal\":{\"name\":\"International Journal of Pathology and Clinical Research\",\"volume\":\"65 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pathology and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2469-5807/1510068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pathology and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2469-5807/1510068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Improvement in the Selection of Patients for Anti-PD1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) Analyzing Tumor Mutational Burden and Retrotransposon Activity as Possible New Biomarker of Effectiveness
Citation: Cobo-Dols M (2018) Improvement in the Selection of Patients for Anti-PD1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) Analyzing Tumor Mutational Burden and Retrotransposon Activity as Possible New Biomarker of Effectiveness. Int J Pathol Clin Res 4:068. doi.org/10.23937/24695807/1510068 Accepted: May 28, 2018: Published: May 30, 2018 Copyright: © 2018 Cobo-Dols M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.